nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—SLC2A1—endothelium—brain cancer	0.0677	0.0924	CbGeAlD
Etomidate—SLC2A1—blood vessel—brain cancer	0.0625	0.0852	CbGeAlD
Etomidate—SLC2A1—hindbrain—brain cancer	0.0596	0.0812	CbGeAlD
Etomidate—SLC2A1—brainstem—brain cancer	0.0342	0.0466	CbGeAlD
Etomidate—SLC2A1—telencephalon—brain cancer	0.0303	0.0413	CbGeAlD
Etomidate—SLC2A1—gonad—brain cancer	0.0253	0.0345	CbGeAlD
Etomidate—Pseudoephedrine—IL2—brain cancer	0.0235	1	CrCbGaD
Etomidate—GABRB2—hindbrain—brain cancer	0.0232	0.0317	CbGeAlD
Etomidate—SLC2A1—midbrain—brain cancer	0.0218	0.0297	CbGeAlD
Etomidate—SLC2A1—spinal cord—brain cancer	0.0212	0.029	CbGeAlD
Etomidate—GABRA1—hindbrain—brain cancer	0.0205	0.028	CbGeAlD
Etomidate—SLC2A1—endocrine gland—brain cancer	0.0191	0.0261	CbGeAlD
Etomidate—SLC2A1—head—brain cancer	0.0189	0.0257	CbGeAlD
Etomidate—SLC2A1—central nervous system—brain cancer	0.0172	0.0235	CbGeAlD
Etomidate—SLC2A1—cerebellum—brain cancer	0.0168	0.023	CbGeAlD
Etomidate—CYP11B1—endocrine gland—brain cancer	0.0164	0.0223	CbGeAlD
Etomidate—CYP11B2—endocrine gland—brain cancer	0.0164	0.0223	CbGeAlD
Etomidate—SLC2A1—brain—brain cancer	0.0137	0.0186	CbGeAlD
Etomidate—GABRB2—brainstem—brain cancer	0.0133	0.0182	CbGeAlD
Etomidate—SLC2A1—Glycolysis and Gluconeogenesis—ENO2—brain cancer	0.013	0.0534	CbGpPWpGaD
Etomidate—GABRG2—telencephalon—brain cancer	0.0118	0.0161	CbGeAlD
Etomidate—GABRB2—telencephalon—brain cancer	0.0118	0.0161	CbGeAlD
Etomidate—GABRA1—brainstem—brain cancer	0.0118	0.016	CbGeAlD
Etomidate—SLC2A1—HIF-2-alpha transcription factor network—SIRT1—brain cancer	0.0112	0.0461	CbGpPWpGaD
Etomidate—GABRA1—telencephalon—brain cancer	0.0104	0.0142	CbGeAlD
Etomidate—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00999	0.0411	CbGpPWpGaD
Etomidate—CYP11B2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00986	0.0406	CbGpPWpGaD
Etomidate—GABRG2—pituitary gland—brain cancer	0.00962	0.0131	CbGeAlD
Etomidate—GABRG2—medulla oblongata—brain cancer	0.00929	0.0127	CbGeAlD
Etomidate—GABRB2—medulla oblongata—brain cancer	0.00929	0.0127	CbGeAlD
Etomidate—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00861	0.0354	CbGpPWpGaD
Etomidate—CYP11B1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.0085	0.035	CbGpPWpGaD
Etomidate—GABRG2—midbrain—brain cancer	0.00849	0.0116	CbGeAlD
Etomidate—GABRB2—midbrain—brain cancer	0.00849	0.0116	CbGeAlD
Etomidate—GABRB2—spinal cord—brain cancer	0.00828	0.0113	CbGeAlD
Etomidate—GABRG2—spinal cord—brain cancer	0.00828	0.0113	CbGeAlD
Etomidate—GABRA1—medulla oblongata—brain cancer	0.0082	0.0112	CbGeAlD
Etomidate—ADRA2B—Platelet Aggregation (Plug Formation)—MPL—brain cancer	0.00817	0.0336	CbGpPWpGaD
Etomidate—CYP11B2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.0081	0.0333	CbGpPWpGaD
Etomidate—CYP19A1—gonad—brain cancer	0.008	0.0109	CbGeAlD
Etomidate—GABRA1—midbrain—brain cancer	0.0075	0.0102	CbGeAlD
Etomidate—GABRG2—head—brain cancer	0.00736	0.01	CbGeAlD
Etomidate—GABRB2—head—brain cancer	0.00736	0.01	CbGeAlD
Etomidate—GABRA1—spinal cord—brain cancer	0.00731	0.00997	CbGeAlD
Etomidate—CYP11B1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00698	0.0287	CbGpPWpGaD
Etomidate—GABRB2—central nervous system—brain cancer	0.00672	0.00916	CbGeAlD
Etomidate—GABRG2—central nervous system—brain cancer	0.00672	0.00916	CbGeAlD
Etomidate—GABRG2—cerebellum—brain cancer	0.00657	0.00895	CbGeAlD
Etomidate—GABRB2—cerebellum—brain cancer	0.00657	0.00895	CbGeAlD
Etomidate—GABRA1—head—brain cancer	0.0065	0.00886	CbGeAlD
Etomidate—CYP19A1—endocrine gland—brain cancer	0.00604	0.00824	CbGeAlD
Etomidate—CYP19A1—head—brain cancer	0.00597	0.00814	CbGeAlD
Etomidate—GABRA1—central nervous system—brain cancer	0.00593	0.00809	CbGeAlD
Etomidate—GABRA1—cerebellum—brain cancer	0.0058	0.00791	CbGeAlD
Etomidate—CYP19A1—central nervous system—brain cancer	0.00545	0.00743	CbGeAlD
Etomidate—GABRG2—brain—brain cancer	0.00533	0.00727	CbGeAlD
Etomidate—GABRB2—brain—brain cancer	0.00533	0.00727	CbGeAlD
Etomidate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00488	0.0201	CbGpPWpGaD
Etomidate—CYP19A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00482	0.0198	CbGpPWpGaD
Etomidate—SLC2A1—HIF-2-alpha transcription factor network—VEGFA—brain cancer	0.00477	0.0196	CbGpPWpGaD
Etomidate—GABRA1—brain—brain cancer	0.00471	0.00642	CbGeAlD
Etomidate—GABRB2—Orphan transporters—S100A10—brain cancer	0.00448	0.0184	CbGpPWpGaD
Etomidate—CYP19A1—brain—brain cancer	0.00432	0.0059	CbGeAlD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—CDK4—brain cancer	0.00432	0.0178	CbGpPWpGaD
Etomidate—CYP11B2—Biological oxidations—CYP2C9—brain cancer	0.0043	0.0177	CbGpPWpGaD
Etomidate—CYP11B2—Metapathway biotransformation—CYP2C9—brain cancer	0.00424	0.0175	CbGpPWpGaD
Etomidate—GABRG2—Orphan transporters—S100A10—brain cancer	0.0041	0.0169	CbGpPWpGaD
Etomidate—CYP19A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00396	0.0163	CbGpPWpGaD
Etomidate—CYP19A1—Ovarian Infertility Genes—ESR2—brain cancer	0.00373	0.0154	CbGpPWpGaD
Etomidate—CYP11B1—Biological oxidations—CYP2C9—brain cancer	0.00371	0.0153	CbGpPWpGaD
Etomidate—CYP11B1—Metapathway biotransformation—CYP2C9—brain cancer	0.00366	0.0151	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.00363	0.0149	CbGpPWpGaD
Etomidate—GABRA1—Orphan transporters—S100A10—brain cancer	0.00358	0.0147	CbGpPWpGaD
Etomidate—SLC2A1—Carbohydrate metabolism—ENO2—brain cancer	0.00343	0.0141	CbGpPWpGaD
Etomidate—SLC2A1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	0.00281	0.0116	CbGpPWpGaD
Etomidate—SLC2A1—Insulin Signaling—IRS2—brain cancer	0.00262	0.0108	CbGpPWpGaD
Etomidate—SLC2A1—Disease—DTX2—brain cancer	0.00249	0.0102	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—HES5—brain cancer	0.00233	0.00959	CbGpPWpGaD
Etomidate—SLC2A1—Insulin Signaling—PIK3CG—brain cancer	0.00231	0.00951	CbGpPWpGaD
Etomidate—CYP19A1—Ovarian Infertility Genes—CDK4—brain cancer	0.00227	0.00935	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—MYC—brain cancer	0.00224	0.00921	CbGpPWpGaD
Etomidate—CYP19A1—Biological oxidations—CYP2C9—brain cancer	0.0021	0.00865	CbGpPWpGaD
Etomidate—CYP19A1—Metapathway biotransformation—CYP2C9—brain cancer	0.00207	0.00853	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—MPL—brain cancer	0.00195	0.00804	CbGpPWpGaD
Etomidate—SLC2A1—Validated targets of C-MYC transcriptional activation—TP53—brain cancer	0.00184	0.00756	CbGpPWpGaD
Etomidate—SLC2A1—Disease—HES5—brain cancer	0.00183	0.00751	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.00167	0.00689	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00165	0.0068	CbGpPWpGaD
Etomidate—GABRB2—Ion channel transport—TRPC6—brain cancer	0.00145	0.00597	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00142	0.00586	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CYP2C9—brain cancer	0.00141	0.00579	CbGpPWpGaD
Etomidate—GABRG2—Ion channel transport—TRPC6—brain cancer	0.00133	0.00546	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—RELA—brain cancer	0.00127	0.00522	CbGpPWpGaD
Etomidate—SLC2A1—Disease—IDH1—brain cancer	0.00123	0.00506	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.00121	0.00497	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—BSG—brain cancer	0.0012	0.00492	CbGpPWpGaD
Etomidate—SLC2A1—Disease—HEY1—brain cancer	0.00116	0.00479	CbGpPWpGaD
Etomidate—GABRA1—Ion channel transport—TRPC6—brain cancer	0.00116	0.00477	CbGpPWpGaD
Etomidate—SLC2A1—Disease—DLL1—brain cancer	0.00114	0.0047	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—IL2—brain cancer	0.00114	0.0047	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—CTNNB1—brain cancer	0.0011	0.00453	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—S100A10—brain cancer	0.00109	0.0045	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.00104	0.00428	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—IDH1—brain cancer	0.00103	0.00423	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—MPL—brain cancer	0.00101	0.00415	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—PTCH2—brain cancer	0.001	0.00413	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—S100A10—brain cancer	0.001	0.00412	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000993	0.00408	CbGpPWpGaD
Etomidate—SLC2A1—Disease—SHH—brain cancer	0.000971	0.004	CbGpPWpGaD
Etomidate—SLC2A1—Disease—ENO2—brain cancer	0.000971	0.004	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—S100A10—brain cancer	0.000966	0.00397	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000886	0.00364	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—OR4C12—brain cancer	0.000881	0.00362	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—OR14C36—brain cancer	0.000881	0.00362	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000875	0.0036	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000869	0.00357	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.000865	0.00356	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ENO2—brain cancer	0.000813	0.00335	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000807	0.00332	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—OR4C12—brain cancer	0.0008	0.00329	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—OR14C36—brain cancer	0.0008	0.00329	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—HES1—brain cancer	0.000771	0.00317	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP2C9—brain cancer	0.000736	0.00303	CbGpPWpGaD
Etomidate—SLC2A1—Disease—VAV1—brain cancer	0.000702	0.00289	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—BSG—brain cancer	0.000681	0.0028	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000657	0.0027	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000648	0.00267	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP2C9—brain cancer	0.000634	0.00261	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—BSG—brain cancer	0.000626	0.00257	CbGpPWpGaD
Etomidate—SLC2A1—Disease—HES1—brain cancer	0.000603	0.00248	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.00059	0.00243	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PDGFRA—brain cancer	0.000575	0.00236	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—BSG—brain cancer	0.000539	0.00222	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—IDH1—brain cancer	0.000538	0.00221	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—SHH—brain cancer	0.000517	0.00213	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PTCH2—brain cancer	0.000515	0.00212	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000505	0.00208	CbGpPWpGaD
Etomidate—SLC2A1—Disease—IRS2—brain cancer	0.000504	0.00208	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—SMO—brain cancer	0.00049	0.00202	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—PTCH1—brain cancer	0.00049	0.00202	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—OR14C36—brain cancer	0.000472	0.00194	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—OR4C12—brain cancer	0.000472	0.00194	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—IDH1—brain cancer	0.000464	0.00191	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000462	0.0019	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TRPC6—brain cancer	0.000446	0.00184	CbGpPWpGaD
Etomidate—SLC2A1—Disease—APC—brain cancer	0.000446	0.00183	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ABR—brain cancer	0.000445	0.00183	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000438	0.0018	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ENO2—brain cancer	0.000425	0.00175	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000424	0.00175	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.00042	0.00173	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	0.000412	0.00169	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ABR—brain cancer	0.000404	0.00166	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000404	0.00166	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DTX2—brain cancer	0.000402	0.00165	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000387	0.00159	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000378	0.00155	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PIK3CG—brain cancer	0.000373	0.00154	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.00037	0.00152	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ENO2—brain cancer	0.000367	0.00151	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP2C9—brain cancer	0.000359	0.00148	CbGpPWpGaD
Etomidate—SLC2A1—Disease—ERBB2—brain cancer	0.000346	0.00142	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.00034	0.0014	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—MYC—brain cancer	0.00034	0.0014	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—VAV1—brain cancer	0.000334	0.00138	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000333	0.00137	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—BSG—brain cancer	0.000306	0.00126	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTCH2—brain cancer	0.000304	0.00125	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CTNNB1—brain cancer	0.000303	0.00125	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HES5—brain cancer	0.000295	0.00121	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IL2—brain cancer	0.00029	0.00119	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—STRADA—brain cancer	0.000286	0.00118	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—TRPC6—brain cancer	0.000282	0.00116	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000279	0.00115	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—SHH—brain cancer	0.000265	0.00109	CbGpPWpGaD
Etomidate—SLC2A1—Disease—STAT3—brain cancer	0.000264	0.00109	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—IDH1—brain cancer	0.000263	0.00108	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—TRPC6—brain cancer	0.000256	0.00105	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—SMO—brain cancer	0.000252	0.00104	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PTCH1—brain cancer	0.000252	0.00104	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—brain cancer	0.000246	0.00101	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MYC—brain cancer	0.000245	0.00101	CbGpPWpGaD
Etomidate—SLC2A1—Disease—EGFR—brain cancer	0.00024	0.000987	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ABR—brain cancer	0.000239	0.000983	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GLI2—brain cancer	0.000231	0.000949	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GLI1—brain cancer	0.000217	0.000893	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000214	0.00088	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PIK3CG—brain cancer	0.000212	0.000873	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—VAV1—brain cancer	0.000211	0.000869	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ENO2—brain cancer	0.000208	0.000855	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SUFU—brain cancer	0.000206	0.000846	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GFAP—brain cancer	0.000198	0.000816	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3CG—brain cancer	0.000195	0.000803	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—VAV1—brain cancer	0.000192	0.000789	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HEY1—brain cancer	0.000188	0.000774	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DLL1—brain cancer	0.000184	0.000759	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3CG—brain cancer	0.000168	0.000692	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SHH—brain cancer	0.000157	0.000645	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TRPC6—brain cancer	0.000151	0.000622	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IL2—brain cancer	0.000149	0.000614	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTCH1—brain cancer	0.000149	0.000612	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SMO—brain cancer	0.000149	0.000612	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PIK3CG—brain cancer	0.000134	0.000552	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—VEGFA—brain cancer	0.000127	0.000522	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PIK3CG—brain cancer	0.000122	0.000501	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOTCH2—brain cancer	0.000119	0.000489	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VAV1—brain cancer	0.000113	0.000466	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HES1—brain cancer	9.74e-05	0.000401	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TP53—brain cancer	9.59e-05	0.000395	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3CG—brain cancer	9.53e-05	0.000392	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—IL2—brain cancer	9.44e-05	0.000388	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PDGFRA—brain cancer	9.28e-05	0.000382	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SPP1—brain cancer	9.01e-05	0.000371	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL2—brain cancer	8.57e-05	0.000353	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IRS2—brain cancer	8.15e-05	0.000335	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APC—brain cancer	7.19e-05	0.000296	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	7.19e-05	0.000296	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—EGFR—brain cancer	6.55e-05	0.00027	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RELA—brain cancer	5.62e-05	0.000231	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ERBB2—brain cancer	5.59e-05	0.00023	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL2—brain cancer	5.06e-05	0.000208	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCND1—brain cancer	4.94e-05	0.000203	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	4.89e-05	0.000201	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VEGFA—brain cancer	4.3e-05	0.000177	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—STAT3—brain cancer	4.26e-05	0.000175	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MYC—brain cancer	3.96e-05	0.000163	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EGFR—brain cancer	3.87e-05	0.000159	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TP53—brain cancer	3.25e-05	0.000134	CbGpPWpGaD
